Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hilton Worldwide
HLT
|
+$717M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$580M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$444M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$406M |
| 5 |
Walt Disney
DIS
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.27B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$1.05B |
| 4 |
Apple
AAPL
|
+$768M |
| 5 |
NVIDIA
NVDA
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.2% |
| 2 | Technology | 7.55% |
| 3 | Healthcare | 7.22% |
| 4 | Energy | 6.62% |
| 5 | Consumer Discretionary | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
CALL
iShares US Transportation ETF
IYT
$2.26B
| $644K | ﹤0.01% |
19,200
-11,200
| -37% | -$389K |
|
|
ASB.WS
4527
DELISTED
Associated Banc-Corp Warrants
ASB.WS
| $644K | ﹤0.01% |
449,606
+500
| +0.1% | +$1.06K |
|
|
FNSR
4528
CALL
DELISTED
Finisar Corp
FNSR
| $644K | ﹤0.01% |
36,800
-7,900
| -18% | -$135K |
|
4529
CALL
Entergy
ETR
$50.2B
| $643K | ﹤0.01% |
15,800
+3,600
| +30% | +$138K |
|
4530
Stoneridge
SRI
$195M
| $643K | ﹤0.01% |
43,016
-1,196,629
| -97% | -$18.1M |
|
4531
PUT
TherapeuticsMD
TXMD
$23.5M
| $643K | ﹤0.01% |
1,512
| – | – |
|
|
KMI.PRA
4532
DELISTED
Kinder Morgan, Inc.
KMI.PRA
| $640K | ﹤0.01% |
13,105
-400,519
| -97% | -$18.3M |
|
4533
PUT
Agilent Technologies
A
$39.1B
| $639K | ﹤0.01% |
14,400
+5,800
| +67% | +$250K |
|
|
CBIO
4534
Crescent Biopharma
CBIO
$535M
| $639K | ﹤0.01% |
879
+606
| +222% | +$418K |
|
4535
PC Connection
CNXN
$2.11B
| $637K | ﹤0.01% |
26,785
+12,972
| +94% | +$310K |
|
4536
National Healthcare
NHC
$3.53B
| $637K | ﹤0.01% |
9,846
+4,016
| +69% | +$255K |
|
|
CS
4537
CALL
DELISTED
Credit Suisse Group
CS
| $637K | ﹤0.01% |
59,500
-45,800
| -43% | -$624K |
|
4538
CALL
W.W. Grainger
GWW
$65.3B
| $636K | ﹤0.01% |
2,800
-1,800
| -39% | -$410K |
|
|
VTAE
4539
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $636K | ﹤0.01% |
58,950
+9,506
| +19% | +$81.3K |
|
4540
PUT
Amkor Technology
AMKR
$12.4B
| $635K | ﹤0.01% |
110,500
+3,200
| +3% | +$18.7K |
|
|
ZAGG
4541
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $635K | ﹤0.01% |
120,871
+11,093
| +10% | +$72.8K |
|
|
CRZO
4542
PUT
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $635K | ﹤0.01% |
17,700
-400
| -2% | -$14.3K |
|
4543
Ducommun
DCO
$2.7B
| $634K | ﹤0.01% |
32,057
+9,844
| +44% | +$168K |
|
|
ECOL
4544
DELISTED
US Ecology, Inc.
ECOL
| $633K | ﹤0.01% |
13,767
-5,101
| -27% | -$226K |
|
4545
CALL
Royal Bank of Canada
RY
$291B
| $632K | ﹤0.01% |
10,700
-2,700
| -20% | -$162K |
|
|
AMT.PRB
4546
DELISTED
American Tower Corporation
AMT.PRB
| $632K | ﹤0.01% |
+5,627
| New | +$594K |
|
4547
PUT
Veeva Systems
VEEV
$33.1B
| $631K | ﹤0.01% |
18,500
+11,500
| +164% | +$342K |
|
|
HRC
4548
PUT
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $631K | ﹤0.01% |
+12,500
| New | +$630K |
|
|
LLL
4549
CALL
DELISTED
L3 Technologies, Inc.
LLL
| $631K | ﹤0.01% |
4,300
+2,200
| +105% | +$296K |
|
4550
CALL
Kilroy Realty
KRC
$4.52B
| $630K | ﹤0.01% |
9,500
-90,200
| -90% | -$5.71M |
|
Similar funds
Goldman Sachs's Q2 2016 Portfolio in Review
As of Q2 2016, Goldman Sachs held 7,605 positions worth $306B, up 0.71% from $304B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs's Q2 2016 filing shows 546 new, 3,268 increased, 2,864 reduced and 595 closed positions. Its largest new stake was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 3,735,711 shares worth $87.8M. The largest sale was Pfizer, an estimated $2.27B.
By sector, the portfolio is most concentrated in Financials at 8.2% of assets, down from 8.6% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 3,735,711 shares worth $87.8M.
- Goldman Sachs added most to Hilton Worldwide in Q2 2016, an estimated $717M increase.
- Goldman Sachs's biggest Q2 2016 reduction was Pfizer, cutting an estimated $2.27B.
- Goldman Sachs fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $1.05B.
- Goldman Sachs's ten largest holdings make up 15% of its $306B portfolio in Q2 2016.
- Goldman Sachs opened 546 new positions and closed 595 in Q2 2016.
- Goldman Sachs's portfolio value rose 0.71% quarter-over-quarter to $306B.
Based on Goldman Sachs's 13F filing for Q2 2016, filed 15 Aug 2016.